BridgeBio Pharma Inc. (1BBIO)
MTA
Real-time Data
07:00 AM
Day's Range
57.7152 wk Range
42.13Overview - 1BBIO - BridgeBio Pharma Inc.
Key Statistics
Valuation
Enterprise Value
12.15B
P/E (Trailing)
‪-15.26‬
PEG Ratio
‪0.85‬
Price / Sales (TTM)
‪15.69‬
Price / Book
‪-4.50‬
EV / EBITDA
‪-29.30‬
Profitability
Gross Margin
‪93.82%‬
Profit Margin
‪-97.02%‬
Operating Margin
‪-43.94%‬
Return on Assets
‪-25.99%‬
Return on Equity
‪34.90%‬
Ownership
Shares Outstanding
195.28M
Float
167.19M
Held by Insiders
‪3.91%‬
Held by Institutions
‪99.69%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪67.42‬
200-Day Avg
‪62.68‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1BBIO - BridgeBio Pharma Inc.
Peers - 1BBIO - BridgeBio Pharma Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1BBIOMTABridgeBio Pharma Inc.11.89BMarket Cap+27.00%52-week change-15.27P/E (Trailing)‪-97.02%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - 1BBIO - BridgeBio Pharma Inc.
About
BridgeBio Pharma Inc. is a commercial-stage biopharmaceutical company focused on developing medicines for genetic conditions. BridgeBio Pharma Inc. discovers, develops, tests, and delivers therapies aimed at patients with rare and inherited diseases, with programs spanning cardiology, endocrinology, muscle disease,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
